Feb 19, 2026 08:39AM
Feb 18, 2026 08:20AM
Feb 13, 2026 08:35AM
Jan 13, 2026 08:55AM
Jan 12, 2026 08:37AM
Dec 23, 2025 04:49PM
Dec 10, 2025 08:30AM Moleculin raises $6.5 million through warrant exercises
Dec 8, 2025 08:21AM
Oct 29, 2025 08:35AM
Sep 10, 2025 07:33AM
Aug 13, 2025 07:11PM
Aug 6, 2025 08:42AM
Jul 30, 2025 08:35AM
Jul 22, 2025 08:40AM JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
Jul 9, 2025 08:37AM
Jun 20, 2025 09:20AM
Jun 18, 2025 07:30AM
Jun 9, 2025 06:14AM
Jun 4, 2025 08:46AM
May 14, 2025 04:30PM
May 12, 2025 08:40AM Moleculin Biotech (MBRX) Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial
May 5, 2025 08:45AM
Apr 29, 2025 08:36AM
Mar 25, 2025 06:52AM
Mar 6, 2025 08:32AM
Mar 3, 2025 06:41AM
Feb 25, 2025 12:35PM
Feb 13, 2025 01:07PM Moleculin Biotech (MBRX) Announces Exercise of Warrants for $5.8M Gross Proceeds
Feb 13, 2025 09:25AM
Feb 11, 2025 08:40AM
Nov 14, 2024 08:16AM
Nov 12, 2024 08:03AM
Aug 16, 2024 08:00AM
Aug 14, 2024 01:25PM
Aug 1, 2024 08:32AM Moleculin Biotech (MBRX) Plans MIRACLE Phase 3 Pivotal Trial
Jul 10, 2024 08:30AM
Jun 14, 2024 08:00AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All